183 related articles for article (PubMed ID: 9069109)
41. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models.
Huugen D; Tervaert JW; Heeringa P
Curr Opin Rheumatol; 2004 Jan; 16(1):4-8. PubMed ID: 14673382
[TBL] [Abstract][Full Text] [Related]
42. Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon.
Russell KA; Specks U
Rheum Dis Clin North Am; 2001 Nov; 27(4):815-32, vii. PubMed ID: 11723766
[TBL] [Abstract][Full Text] [Related]
43. Intravital microscopy in the study of ANCA-associated systemic vasculitis.
Little MA; Pusey CD; Nourshargh S
Clin Nephrol; 2005 Dec; 64(6):465-70. PubMed ID: 16370161
[TBL] [Abstract][Full Text] [Related]
44. Neutrophil extracellular traps in vasculitis, friend or foe?
Söderberg D; Segelmark M
Curr Opin Rheumatol; 2018 Jan; 30(1):16-23. PubMed ID: 28957962
[TBL] [Abstract][Full Text] [Related]
45. [Antibodies against neutrophil cytoplasm and their role in pathology and diagnosis of systemic vasculitis].
Kacprzyk F; Fijałkowska-Morawska J
Postepy Hig Med Dosw; 1994; 48(5):603-14. PubMed ID: 7638103
[TBL] [Abstract][Full Text] [Related]
46. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.
Heeringa P; Brouwer E; Tervaert JW; Weening JJ; Kallenberg CG
Kidney Int; 1998 Feb; 53(2):253-63. PubMed ID: 9461083
[No Abstract] [Full Text] [Related]
47. Glomerulonephritis in the vasculitides: advances in immunopathology.
Hauer HA; Hagen EC; de Heer E; Bruijn JA; Bajema IM
Curr Opin Rheumatol; 2003 Jan; 15(1):17-21. PubMed ID: 12496505
[TBL] [Abstract][Full Text] [Related]
48. Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro.
Popat RJ; Robson MG
Ann Rheum Dis; 2019 May; 78(5):709-711. PubMed ID: 30514699
[No Abstract] [Full Text] [Related]
49. Leukocyte-endothelial interactions in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Harper L; Savage CO
Rheum Dis Clin North Am; 2001 Nov; 27(4):887-903. PubMed ID: 11723770
[TBL] [Abstract][Full Text] [Related]
50. L8. Animal models of ANCA associated vasculitis: the contribution of autoantibodies and autoreactive T cells.
Heeringa P
Presse Med; 2013 Apr; 42(4 Pt 2):515-7. PubMed ID: 23453995
[No Abstract] [Full Text] [Related]
51. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming.
Gilligan HM; Bredy B; Brady HR; Hébert MJ; Slayter HS; Xu Y; Rauch J; Shia MA; Koh JS; Levine JS
J Exp Med; 1996 Dec; 184(6):2231-41. PubMed ID: 8976178
[TBL] [Abstract][Full Text] [Related]
52. Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils.
Yang JJ; Tuttle RH; Hogan SL; Taylor JG; Phillips BD; Falk RJ; Jennette JC
Clin Exp Immunol; 2000 Jul; 121(1):165-72. PubMed ID: 10886255
[TBL] [Abstract][Full Text] [Related]
53. Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?
Muller Kobold AC; Mesander G; Stegeman CA; Kallenberg CG; Tervaert JW
Clin Exp Immunol; 1998 Dec; 114(3):491-9. PubMed ID: 9844062
[TBL] [Abstract][Full Text] [Related]
54. Dying neutrophils in ANCA-associated vasculitis: good or bad guys?
Kallenberg CG
Kidney Int; 2002 Feb; 61(2):758-9. PubMed ID: 11849420
[No Abstract] [Full Text] [Related]
55. Pathophysiological importance of antineutrophil antibodies in vasculitis.
Basu N; Erwig LP
Curr Opin Hematol; 2011 Jan; 18(1):25-9. PubMed ID: 20975556
[TBL] [Abstract][Full Text] [Related]
56. The evolving pathogenesis of systemic vasculitis.
Savage CO
Clin Med (Lond); 2002; 2(5):458-64. PubMed ID: 12448596
[TBL] [Abstract][Full Text] [Related]
57. ANCA vasculitis meets epigenetics--closing in on the molecular roots of disease.
Zeisberg M
Nephrol Dial Transplant; 2011 Apr; 26(4):1146-8. PubMed ID: 21273237
[No Abstract] [Full Text] [Related]
58. [NETs in pathogenesis of vasculitis].
Nakazawa D; Nishio S; Tomaru U; Atsumi T; Ishizu A
Nihon Jinzo Gakkai Shi; 2014; 56(2):117-23. PubMed ID: 24730349
[No Abstract] [Full Text] [Related]
59. Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies.
Jennette JC; Falk RJ
Adv Exp Med Biol; 1993; 336():7-15. PubMed ID: 8296677
[No Abstract] [Full Text] [Related]
60. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.
Jennette JC; Falk RJ
Nat Rev Rheumatol; 2014 Aug; 10(8):463-73. PubMed ID: 25003769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
